Skip to main navigation Skip to search Skip to main content

Interaction of PAH-related compounds with the α and β isoforms of the estrogen receptor

  • K. C. Fertuck
  • , S. Kumar
  • , H. C. Sikka
  • , J. B. Matthews
  • , T. R. Zacharewski
  • Michigan State University
  • Buffalo State College, State University of New York

Research output: Contribution to journalArticlepeer-review

116 Scopus citations

Abstract

The ability of several 4- and 5-ring polycyclic aromatic hydrocarbons (PAHs), heterocyclic PAHs, and their monohydroxy derivatives to interact with the estrogen receptor (ER) alpha and beta isoforms was examined. Only compounds possessing a hydroxyl group were able to compete with 3H-labeled 17β-estradiol (E2) for binding to either a glutathione-S-transferase and human ERα D, E, and F domain fusion protein (GST-hERαdef) or to the full-length human ERβ. Competitive binding was comparable for both isoforms, with IC50 values ranging from 20 to 300 nM (E2 IC50 approximately 3 nM). However, several compounds were able to induce reporter gene expression preferentially through mERβ, using MCF-7 cells transiently transfected with either a Gal4-human ERαdef or Gal4-mouse ERβdef construct, as well as a Gal4-regulated reporter. These data extend the number and type of PAH-related compounds capable of interacting with ERα and ERβ, and provides additional evidence that even though some compounds may possess a similar affinity for both ER isoforms, the capacity for transcriptional activation can still be isoform-specific.

Original languageEnglish
Pages (from-to)167-177
Number of pages11
JournalToxicology Letters
Volume121
Issue number3
DOIs
StatePublished - May 19 2001

Keywords

  • Estrogen receptor
  • Estrogenic endocrine disruptor
  • Heterocyclic PAHs
  • Monohydroxy PAHs
  • PAHs

Fingerprint

Dive into the research topics of 'Interaction of PAH-related compounds with the α and β isoforms of the estrogen receptor'. Together they form a unique fingerprint.

Cite this